Verastem Stock Price on December 3, 2024

VSTM Stock  USD 4.90  0.10  2.00%   
Below is the normalized historical share price chart for Verastem extending back to January 27, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Verastem stands at 4.90, as last reported on the 11th of December 2024, with the highest price reaching 5.00 and the lowest price hitting 4.90 during the day.
IPO Date
27th of January 2012
200 Day MA
5.8208
50 Day MA
3.7924
Beta
0.136
 
Yuan Drop
 
Covid
If you're considering investing in Verastem Stock, it is important to understand the factors that can impact its price. Verastem is slightly risky given 3 months investment horizon. Verastem owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.12% are justified by taking the suggested risk. Use Verastem Coefficient Of Variation of 507.0, risk adjusted performance of 0.1513, and Semi Deviation of 4.9 to evaluate company specific risk that cannot be diversified away.
  
At this time, Verastem's Total Stockholder Equity is very stable compared to the past year. As of the 11th of December 2024, Common Stock Shares Outstanding is likely to grow to about 23.2 M, while Liabilities And Stockholders Equity is likely to drop about 134.7 M. . At this time, Verastem's Price To Sales Ratio is very stable compared to the past year. As of the 11th of December 2024, Price Book Value Ratio is likely to grow to 3.29, while Price To Operating Cash Flows Ratio is likely to drop (2.18). Verastem Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1774

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsVSTM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 6.32
  actual daily
56
56% of assets are less volatile

Expected Return

 1.12
  actual daily
22
78% of assets have higher returns

Risk-Adjusted Return

 0.18
  actual daily
13
87% of assets perform better
Based on monthly moving average Verastem is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verastem by adding it to a well-diversified portfolio.
Price Book
22.0923
Enterprise Value Ebitda
(0.19)
Price Sales
24.4341
Shares Float
44.3 M
Wall Street Target Price
11.125

Related Headline

Viking Therapeutics Headline on 3rd of December 2024

Theres a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers for their businesses. At a cheaper valuation, has Viking Therapeutics become too good of a buy to pass up right now Although it looks like there may be some mounting pessimism surrounding Viking Therapeutics stock recently, its shares are still up more than 180 percent this year, as of the end of last week.

Verastem Valuation on December 3, 2024

It is possible to determine the worth of Verastem on a given historical date. On December 3, 2024 Verastem was worth 5.51 at the beginning of the trading date compared to the closed value of 5.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Verastem stock. Still, in general, we apply an absolute valuation method to find Verastem's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verastem where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Verastem's related companies.
 Open High Low Close Volume
  5.40    5.70    5.12    5.52    1,938,277  
12/03/2024
  5.51    6.01    5.28    5.39    2,706,064  
  5.39    5.56    5.30    5.49    662,997  
Backtest Verastem  |  Verastem History  |  Verastem Valuation   PreviousNext  
Open Value
5.51
5.39
Closing Value
24.47
Upside

Verastem Trading Date Momentum on December 3, 2024

On December 04 2024 Verastem was traded for  5.49  at the closing time. The top price for the day was 5.56  and the lowest listed price was  5.30 . The trading volume for the day was 663 K. The trading history from December 4, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 1.86% . The trading price change against the current closing price is 7.24% .

Verastem Fundamentals Correlations and Trends

By evaluating Verastem's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Verastem's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Verastem financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Verastem Stock history

Verastem investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verastem is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verastem will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verastem stock prices may prove useful in developing a viable investing in Verastem
Last ReportedProjected for Next Year
Common Stock Shares Outstanding22.1 M23.2 M
Net Loss-66.4 M-69.8 M

Verastem Quarterly Net Working Capital

83.29 Million

Verastem Stock Technical Analysis

Verastem technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Verastem technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Verastem trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Verastem Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Verastem cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Verastem December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Verastem stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verastem shares will generate the highest return on investment. By undertsting and applying Verastem stock market strength indicators, traders can identify Verastem entry and exit signals to maximize returns

Verastem Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Verastem's price direction in advance. Along with the technical and fundamental analysis of Verastem Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verastem to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
0.331
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(1.37)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.